Wealthy Private Practice OB/GYNs in the US
- **Dr. Thaïs Aliabadi – Beverly Hills/Los Angeles, CA**
- Practice: Private OB/GYN practice at Cedars-Sinai Medical Office Towers in Los Angeles (near Beverly Hills).
- Wealth Indicators: Serves as the official gynecologist for multiple royal families and high-profile celebrities . Her elite clientele includes members of the Kardashian/Jenner family – notably, her patient Kylie Jenner donated $1 million to a COVID-19 relief fund that Dr. Aliabadi organized in 2020 . Such connections underscore her well-established, luxury-oriented practice.
- Contact: [email protected]
- **Dr. Simone Whitmore – Duluth (Atlanta), GA**
- Practice: Owner and solo practitioner of North Perimeter OB/GYN in Duluth, GA (metro Atlanta). She has run this private practice since 2004 .
- Wealth Indicators: Gained national fame as a cast member of Bravo’s Married to Medicine, leveraging her platform as a successful OB/GYN practice owner . She is known as a sought-after speaker on women’s health and, outside of medicine, she and her husband invest in upscale residential real estate in Atlanta – an additional signal of wealth. Her long-running practice, media presence, and investments all point to substantial financial success.
- Contact: [email protected]
OB/GYN Practice Management Groups
- Unified Women’s Healthcare
- Geographic Coverage: National – affiliates in roughly 18–20 states across the U.S. (and North America). It is the largest OB/GYN practice management platform, with nearly 900 practice locations under its umbrella .
- Affiliated Practices: Supports over 2,500 OB/GYN providers across ~900 sites , making it the largest physician practice management company devoted solely to women’s health in the U.S. . Practices retain clinical autonomy while benefiting from Unified’s management services.
- Financial Indicators: Private equity–backed – investors include Altas Partners, Ares Management, and Oak HC/FT . Unified was originally formed in 2013 with capital from Ares, and has grown via major acquisitions and partnerships. In 2021 it acquired Women’s Health USA (WHUSA), another large OB/GYN management company, to expand its network . This combination created a powerhouse platform and brought WHUSA’s investor (Sverica) on as a minority stakeholder . Unified has also attracted growth investment from Altas Partners (new lead investor as of 2020) and Oak HC/FT, signaling strong financial backing.
- Partnerships & Biotech/Lab Connections: Unified has formed strategic alliances to broaden its services. Notably, it entered a partnership with CCRM Fertility (a leading IVF & fertility network) to integrate reproductive medicine into its platform . This allows Unified-affiliated OB/GYNs to offer advanced fertility services through CCRM’s labs and clinics. Unified has also expanded into menopause and digital health via Gennev (an online menopause care platform, now a Unified affiliate led by Jill Angelo) . These partnerships illustrate Unified’s approach to cover the full spectrum of women’s health services (from fertility to menopause) and leverage innovative healthcare technology.
- Contact
- Axia Women’s Health
- Geographic Coverage: Multi-state (national footprint under development). Axia is based in New Jersey/Pennsylvania and is one of the largest OB/GYN groups in the Northeast; it has expanded into the Midwest in recent years as part of building a national platform . As of 2021, Axia had affiliated practices in NJ, PA, and several Midwestern states (e.g. Indiana, Ohio), with plans to continue growing across the U.S. .
- Affiliated Practices: Axia partners with 80+ care centers (~150 practice locations) and supports a community of hundreds of providers serving roughly 475,000–500,000 patients annually . By 2022, it grew to about 200 locations caring for over 500,000 patients per year . Axia-affiliated clinics offer comprehensive women’s health services ranging from general OB/GYN to subspecialties.
- Financial Indicators: Private equity backed – Axia was created in 2017 via a platform investment by Audax Private Equity, and it completed 18 add-on acquisitions under Audax’s ownership (2017–2021) to fuel growth (including expansion into the Midwest) . In 2021, Audax sold Axia to Partners Group (a global PE firm) in a deal reportedly valued around $800M . This transition to Partners Group provides Axia with substantial capital for further expansion. The company’s aggressive M&A strategy (18 practice acquisitions in four years ) and the backing of large PE firms underscore its financial stability and growth trajectory.
- Partnerships & Lab Services: Axia’s model emphasizes integrated services. The network offers in-house laboratory, imaging, and fertility services across its centers – for example, many Axia sites provide on-site lab testing, mammography, urogynecology, and fertility treatment as part of a one-stop care model . This vertical integration is a value proposition for Axia (ensuring patients can get lab tests, mammograms, etc., within the Axia system). Axia has not publicly announced external biotech partnerships, as it has focused on building these capabilities internally. Its comprehensive service line (from routine OB/GYN to advanced fertility and diagnostics) indicates strong investment in clinical infrastructure rather than reliance on third-party labs .
- Contact
- Women’s Care (Women’s Care Enterprises, formerly Women’s Care Florida)
- Geographic Coverage: Regional multi-state – headquartered in Florida (Tampa area) with a dominant presence across Florida, and expanding into other states. In recent years Women’s Care entered Arizona, California, and Kentucky markets, evolving from a Florida-only group into a broader women’s health platform . (It is one of the largest OB/GYN groups in the Southeast and now has a growing footprint in the West.)
- Affiliated Practices: Women’s Care employs over 250 physicians along with 130+ mid-level providers (nurse-midwives, NPs) . Collectively, its providers see nearly 1 million patient visits per year . In Florida, Women’s Care has dozens of locations (including in North, Central, and South Florida), and through recent partnerships, it has added multiple clinics in KY, CA, and AZ . This scale makes it one of the largest OB/GYN enterprises in its regions.
- Financial Indicators: Private equity backed – Women’s Care has undergone two major PE sponsorships. In 2017, Lindsay Goldberg acquired Women’s Care Florida, and in December 2020 BC Partners acquired Women’s Care Enterprises (WCE) to fuel further growth . The BC Partners buyout (reported near a $900M valuation ) provided substantial capital. Under PE ownership, Women’s Care has actively pursued M&A: it has integrated multiple independent OB/GYN groups in Florida. For example, WCE formed alliances with Palm Beach OB/GYN and North Florida OB/GYN, providing those groups “substantial capital, management talent and resources” to expand services as part of Women’s Care . These mergers have expanded WCE’s provider base and geographic reach. The consistent PE interest (Lindsay Goldberg then BC Partners) and ongoing acquisitions signal strong financial support and stability.
- Partnerships & Services: Women’s Care focuses on comprehensive in-house services for women’s health. The group has developed its own ancillary services – for instance, it launched a central clinical laboratory to support its OB/GYN offices (hiring a dedicated lab medical director to run it) , and offers on-site services like ultrasound, mammography, fertility treatment, and surgery across its network . This diversification (lab, imaging, fertility) is part of WCE’s strategy to provide full-spectrum care and additional revenue streams. In terms of external partnerships, Women’s Care primarily grows by partnering with local OB/GYN practices (rather than, say, pharma/biotech deals). Its partnerships are typically mergers/affiliations – for example, aligning with North Florida OB/GYN and others to expand regional presence . These affiliations bring in external practices under the WCE umbrella with infused capital for growth. There haven’t been highly publicized collaborations with biotech firms; however, WCE’s robust internal lab and fertility services mean it has the capability to perform advanced testing (genetic screenings, IVF lab work, etc.) in-house or via established vendors.
- Contact
- OB Hospitalist Group (OBHG)
- Geographic Coverage: National – OBHG is present in 34–37 states, making it the largest obstetric hospitalist provider in the U.S. It partners with over 235 hospitals nationwide to provide on-site OB/GYN hospitalist programs . (These include hospitals across the country, covering a wide geographic range from coast to coast.)
- Affiliated Practices: OBHG isn’t an office-based practice group but rather a hospital-focused physician management group. It employs 1,100+ OB clinicians (OB/GYN physicians and midwives) who staff labor & delivery units at client hospitals . The company manages around 235 hospital programs in 37 states as of 2021 , providing 24/7 in-hospital coverage for obstetric emergencies and deliveries. This scale makes OBHG the largest dedicated OB hospitalist group in the nation (serving more hospitals than any competitor).
- Financial Indicators: Private equity supported – OBHG’s rapid growth has been funded by major PE investors. In 2017, Gryphon Investors acquired OBHG, and under Gryphon the company roughly doubled the number of hospitals it served . In 2021, Kohlberg & Company (PE firm) acquired OBHG from Gryphon . This succession of PE partnerships underscores OBHG’s financial strength and investor confidence. OBHG has also shown strong organic growth (a 105% revenue growth over three years, earning it a spot on the Inc. 5000 list of fast-growing companies) . The backing of Kohlberg (which keeps OBHG in its current portfolio) provides continued access to capital for expansion into new hospital markets.
- Partnerships & Biotech Connections: OBHG’s “partnerships” are primarily with hospitals and health systems. The core of its business is contractual partnerships to provide OB hospitalist services within hospitals, rather than collaborations with pharma or biotech companies. OBHG embeds its physicians in hospital labor & delivery units, working closely with hospital maternity departments to improve outcomes (e.g., reducing ER admits, lowering malpractice risk) . There are no publicly noted partnerships with lab or biotech firms – since OBHG’s focus is clinical service delivery, not product development. (OBHG physicians do coordinate with hospital labs and blood banks as part of patient care, but those are standard hospital operations rather than unique partnerships.) In summary, OBHG’s alliances are with hospital systems and its value-add is operational (staffing and protocols), making biotech/lab collaborations outside the scope of its practice management role.
- Contacts
- Advantia Health
- Geographic Coverage: National (with a growing regional presence). Advantia is based in the Mid-Atlantic (Arlington, VA/Washington D.C. area) and has expanded into the Midwest. It currently operates around 60 locations across multiple states – primarily in Washington D.C., Maryland, Virginia, and the Illinois/Missouri region (following a major acquisition in Illinois). This network serves hundreds of thousands of patients, and the company positions itself as a tech-enabled national women’s health provider .
- Affiliated Practices: Advantia encompasses 200+ providers at ~60 care sites, caring for over 430,000 patients annually . Its clinics offer integrated care – not just OB/GYN, but also primary care, mental health, and related women’s health specialties . A notable affiliate is Heartland Women’s Healthcare in Illinois/Missouri (acquired in 2019), which nearly doubled Advantia’s size and gave it a Midwestern footprint . Advantia also runs flagship multi-specialty women’s centers (combining OB/GYN, mental wellness, etc.) and a telehealth service for new mothers.
- Financial Indicators: Venture capital/Private equity backed – Advantia has raised over $100 million in funding. In early 2020, it secured a $45 million growth investment led by BlueMountain Capital , which was its largest funding round to date (prior to that, it had raised about $65M in earlier rounds) . These funds have been used to accelerate expansion (opening new comprehensive care centers in D.C.) and to pursue acquisitions . Advantia’s strategy has indeed included M&A: for example, in 2019 it acquired Heartland Women’s Healthcare, a large OB/GYN group in Illinois, via a cash-and-stock deal . That acquisition significantly expanded its provider count and geographic reach. It also acquired Pacify Health, a telehealth app providing 24/7 newborn and maternal support , reflecting a focus on digital health integration. The combination of traditional VC funding (from firms like BlueMountain, Deerfield, etc.) and a track record of acquisitions indicates solid financial support and a growth-focused approach.
- Partnerships & Biotech/Lab Connections: Advantia has a strong focus on integrating technology and ancillary services into women’s health. A recent notable partnership is with Assured Imaging (Rezolut) to bring advanced breast imaging directly into Advantia clinics. In December 2024, Advantia announced that Assured Imaging, a national breast health provider, is partnering with Advantia to provide 3D mammography on-site at Advantia’s offices . This means patients can get state-of-the-art digital mammograms (with AI-driven analysis) in the same visit as their OB/GYN appointment, enhancing convenience and care quality . Such a collaboration highlights Advantia’s strategy of embedding high-tech services (like advanced imaging) within its practice network. In addition, Advantia leverages digital health – e.g., its Pacify app offers tele-lactation and postpartum support to patients, and the company emphasizes a “tech-enabled” patient experience. While not a biotech firm per se, Advantia’s model involves partnering with specialized healthcare service providers (imaging, telehealth, etc.) to broaden its clinical offerings. No direct pharmaceutical or biotech research partnerships are public, but the integration of services like on-site labs, imaging, and telehealth indicates a modern, connected care approach.
- Contacts
- Nova Women’s Health Partners
- Geographic Coverage: Midwest (emerging platform). Nova Women’s Health Partners launched in late 2024 with an initial focus in Illinois and plans to expand across the greater Midwest region . The founding practices are based in the Chicago suburban area, and Nova’s strategy is to grow by affiliating with additional women’s health groups throughout Illinois and neighboring states .
- Affiliated Practices: Nova is a new consortium of OB/GYN practices, formed by merging two well-established groups in Illinois: WomanCare PC and Women’s HealthFirst . Together, these founding practices bring multiple clinic locations and dozens of providers under the Nova umbrella. (For context, WomanCare has 4 clinic locations in Chicago’s suburbs , and Women’s HealthFirst has several offices as well – the merger creates a regional network of clinics.) While currently comprising those two groups, Nova is actively looking to add “like-minded women’s health groups” as additional affiliates in the Midwest . This physician-led platform is in the early stages but has a clear growth mandate.
- Financial Indicators: Private equity backed (new platform) – Nova was formed in partnership with Webster Equity Partners in 2024. Webster, a healthcare-focused PE firm, created Nova as a platform investment by bringing WomanCare and Women’s HealthFirst together . This means Nova has significant financial backing from Webster Equity to fund practice acquisitions and expansion. The deal to form Nova closed in Dec 2024 , and it represents one of the latest investments in the consolidating OB/GYN sector. While specific funding amounts aren’t public, Webster’s involvement signals that Nova has the capital and support to execute a “broader growth strategy” – plans include expanding service offerings, building out infrastructure, and scaling across Illinois and beyond . The creation of Nova is a notable M&A event itself, combining two independent physician groups into a single entity with PE support. Future add-on acquisitions in 2025 and beyond are expected as part of Webster’s growth play.
- Partnerships & Biotech Connections: Nova’s focus at this stage is internal growth and consolidation rather than external partnerships. The platform’s immediate goal is to integrate its founding practices and enhance their service offerings (for instance, leveraging combined resources to maybe add ancillary services over time) . There have not been any biotech or lab service partnerships announced – which is expected given Nova just formed. The likely next step for Nova is partnering with more OB/GYN practices (i.e., practice acquisition partnerships) across the Midwest, as opposed to teaming up with biotech companies. As the organization grows, it may explore collaborations (for example, contracting with lab companies for genetics or IVF services, if those aren’t handled in-house), but none are public yet. Right now, Nova’s key “partnerships” are essentially the affiliations between the member practices and building a cohesive group out of those. The formation press release emphasized plans to expand service infrastructure and collaborate with other regional women’s health groups to improve care delivery in the Midwest . This suggests that down the line Nova will be engaging additional practices (and possibly ancillary service providers) to broaden its capabilities, but those developments are to be watched in the future.
- Contacts